Inactive Instrument
Phosphagenics Limited Stock Australian S.E.
Stocks
AU000000POH7
Pharmaceuticals
OTC Markets Traded| Market Cap | 42.13M 29.72M 25.67M 23.65M 22.14M 41.49M 2.82B 279M 109M 1.37B 112M 109M 4.76B | P/E Ratio 2024 |
-2.5x | P/E Ratio 2025 | -6.43x |
|---|---|---|---|---|---|
| Enterprise Value | 37.49M 26.44M 22.84M 21.04M 19.7M 36.91M 2.51B 248M 96.88M 1.22B 99.23M 97.11M 4.24B | EV / Sales 2024 |
5.85x | EV / Sales 2025 | 23x |
| Free-Float |
75.85% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -14.29% |
| Manager | Title | Age | Since |
|---|---|---|---|
Paul David Gavin
CEO | Chief Executive Officer | - | 2020-04-30 |
Roksan Libinaki
COO | Chief Operating Officer | - | 2020-04-30 |
Naomi Lawrie
SEC | Corporate Secretary | - | 2026-04-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Ross Murdoch
BRD | Director/Board Member | - | 2015-04-12 |
Gregory Collier
CHM | Chairman | - | 2018-12-31 |
Kathy Connell
BRD | Director/Board Member | 59 | 2024-04-25 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -14.29% | -14.29% | - | - | 29.72M | ||
| -2.41% | +0.14% | +38.28% | +154.20% | 1,010B | ||
| +1.07% | +3.48% | +53.32% | +49.85% | 580B | ||
| +1.32% | +0.22% | +19.18% | +64.65% | 402B | ||
| +0.77% | 0.00% | +21.28% | +16.70% | 330B | ||
| +0.44% | +3.48% | +25.65% | +35.66% | 281B | ||
| -0.85% | -2.86% | +22.54% | +14.67% | 280B | ||
| +1.66% | +1.20% | -44.35% | -47.35% | 197B | ||
| +0.32% | +1.61% | +20.32% | +60.01% | 192B | ||
| -0.22% | -2.76% | +14.19% | +60.09% | 156B | ||
| Average | -1.22% | +0.84% | +18.93% | +45.39% | 380.99B | |
| Weighted average by Cap. | -0.23% | +1.04% | +27.77% | +70.54% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 1.13M 799K 690K 636K 595K 1.12M 75.94M 7.51M 2.93M 36.96M 3M 2.93M 128M | 1.24M 873K 754K 695K 650K 1.22M 82.98M 8.2M 3.2M 40.39M 3.28M 3.21M 140M |
| Net income | -3.12M -2.2M -1.9M -1.75M -1.64M -3.07M -209M -20.69M -8.07M -102M -8.26M -8.09M -353M | -4.42M -3.12M -2.69M -2.48M -2.32M -4.35M -296M -29.28M -11.41M -144M -11.69M -11.44M -499M |
| Net Debt | -1.3M -915K -791K -729K -682K -1.28M -87.01M -8.6M -3.35M -42.35M -3.44M -3.36M -147M | -4.65M -3.28M -2.83M -2.61M -2.44M -4.58M -312M -30.82M -12.01M -152M -12.31M -12.04M -525M |
Employees
-
Sector
Pharmaceuticals
















